Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claire Ann Jones has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reduction in unnecessary oxytocin administration for elective first trimester suction dilation and curettage

    by Ghazal Danesh, Stephanie Dephoure, Praniya Elangainesan, Stella Wang, Ella Huszti, Kyle Kirkham, Claire Ann Jones, Julie G. Thorne

  • Reduction of Unnecessary in-Person Visits During an in Vitro Fertilization Cycle While Maintaining High Quality Patient Care

    by Salina Kanji, Victoria O'DRiscoll, Heather Shapiro, Crystal Chan, Qixuan Li, Ella Huszti, Claire Ann Jones

    Introduction: In vitro fertilization (IVF) cycles typically require multiple in-person visits for blood tests and ultrasonography to monitor the response to gonadotropins and predict treatment outcomes. The aim of the quality improvement project was to reduce the number of in-person visits for patients undergoing IVF while maintaining high-quality patient care. Methods: A multimodal quality improvement (QI) initiative was implemented for patients undergoing IVF through changes to the default settings in the electronic medical record and staff education. Data were collected prospectively for all patients undergoing IVF from June to August 2020 and retrospectively from June to August 2019. Results: A total of 178 and 202 IVF cycles were included in the preintervention and postintervention periods, respectively. The median number of visits per IVF cycle was reduced by 50% in the postintervention period compared with baseline (4.00 [3.00, 5.00] vs. 8.00 [7.00, 8.00], p < .001). There were no statistically significant differences in the odds of having more than 20 oocytes retrieved (OR 1.568; 95% CI 0.91–2.703), moderate or severe ovarian hyperstimulation syndrome (OHSS) symptoms (OR 1.08, 95% CI 0.17–6.73), or pregnancy rate per embryo transfer (OR 0.82, 95% CI 0.45–1.50). A high level of patient satisfaction was observed. Conclusions: In-person visits during an IVF cycle were rapidly reduced, with good patient satisfaction and no statistically significant differences in outcomes.

  • Open Access

    Shift Work as a Potential Risk Factor for Lower Ovarian Reserve: A Study of Fertility Patients

    by Adeolu Banjoko, Nina Harris, Sara Mousavi, Stella Wang, Ella Huszti, Zachary M. Ferraro, Claire Ann Jones

    Background/Objectives: Shift work is a form of circadian dysregulation, which has been associated with adverse reproductive health outcomes. However, the association between circadian dysregulation and ovarian reserve remains uncertain. The present study examines whether shift work is associated with lower AMH levels in women seeking fertility treatment. Methods: This retrospective cohort study includes female patients aged 20–39 years presenting between February 2023 and June 2024. Patients were excluded if they had only one ovary, a current cancer diagnosis, or past chemotherapy use. Demographic and medical data were obtained from the electronic medical record. AMH levels were compared between daytime workers and shift workers. Results: A total of 1135 patients met inclusion criteria. The median age was 35 years (IQR 32–37). Of these, 89% (n = 1014) reported daytime work, and 11% (n = 121) reported shift work, comprising 102 working rotating shifts, seven working night shifts, and 12 working evening shifts. Daytime-only workers had a median AMH of 17.20 pmol/L (9.1–30.0). Combined shift workers had a median AMH of 17.10 pmol/L (8.1–31.0). There was no statistically significant difference in AMH levels between daytime workers and shift workers (p = 0.935). Although not significant, the odds of having low AMH levels (p = 0.345). Conclusions: In this cohort, AMH levels did not significantly differ between daytime and shift workers, offering reassurance to individuals required to engage in shift work. Future research should include larger cohorts and incorporate more comprehensive measures of circadian disruption.

  • Open Access

    Eliminating Routine Maternal Blood Work After Cesarean Birth: A Quality Improvement Project

    by Yannay Khaikin, Harsukh Benipal, Jackie Thomas, Jodi L. Shapiro, Andrea Page, Claire A. Jones

    Objective: Low-value laboratories lead to healthcare inefficiencies, unnecessary interventions, and environmental waste. Maternal complete blood count (CBC) testing is routine after cesarean birth, but does not change clinical management in most cases. We aimed to decrease routine postpartum CBC testing at a tertiary-care hospital and replace it with targeted ordering for patients at increased risk of severe anemia. Methods: After reviewing baseline practices, we implemented a quality improvement intervention with two plan-do-study-act (PDSA) cycles. The intervention involved modification of the CBC order in the electronic postpartum order set and creation of ordering criteria: hemoglobin ≤110g/L, above average blood loss, or operating time. The primary outcome was the postpartum CBC draw proportion. Short- and long-term data were collected and evaluated using a run chart. Results: During PDSA2, we observed a reduction in CBC draws from 99% to 34% (n = 202). Nine patients met criteria for CBC but did not have a draw; none had signs or symptoms of anemia. Decrease in draws was stable at 1 year. Detection of severe anemia (≤70 g/L) was unchanged before and after intervention (2.4 vs. 2.3%, p = .88). Conclusions: Our intervention resulted in a significant and sustained change in postpartum CBC ordering. Similar initiatives should consider modifying ordering criteria to suit local trends.


  • Initial assessment of infertility in primary care

    by Claire Ann Jones, Akanksha Kulshreshtha, Karen Born, Parul Katiyar


  • Interventions Used to Improve Communication Competencies in Surgical Residencies: A Systematic Review

    by Dalia Karol, Aleena Malik, Eleni Philippopoulos, Kameela Alibhai, Claire Jones, Evan Tannenbaum


  • TRANSMYOMETRIAL EMBRYO TRANSFER (TMET) IN A PATIENT WITH A HISTORY OF RADICAL TRACHELECTOMY

    by Claire Jones, Justin Tan, Pat Chronis-Brown, Nigel Pereira

  • Patients' preferences for distributing limited government‐funded IVF cycles

    by Claire Ann Jones, Tamas Gotz, Nipa Chauhan, Sydney Goldstein, Angela Assal

    Objective: On December 21, 2015, Ontario began funding one cycle of IVF for each resident with a uterus under the age of 43, but with a program cap that is insufficient to meet the annual demand. Our objective was to determine how fertility patients believe that the limited number of funded IVF cycles should be distributed.Methods: A survey was distributed to patients attending a university affiliated hospital‐based fertility clinic in downtown Toronto, including its associated peripheral satellite clinics.Results: From August 2016 to March 2017, 271 patients responded to the survey, of whom 90.3% were in favour of public funding for IVF. The majority of participants favoured allocating IVF cycles to maximize patients’ access to IVF in Ontario rather than targeting funded IVF cycles so as to maximize live births (62.7% vs. 32.8%). Most participants wanted all clinics to adopt the same approach for distributing funded IVF cycles compared to the current system in which each clinic chooses its own criteria for allocation (84.5% vs. 8.5%). Participants favoured distributing IVF by way of a scoring system that took individual patient factors into account. However, the factors that each respondent considered important varied materially.Conclusion: Patients overwhelmingly supported public funding for IVF, desired a consistent policy for distribution of limited funded IVF cycles at all clinics, and preferred a method that took individual patient factors into consideration when determining patient priority for funded IVF but there were heterogenous opinions on which factors should be included.


  • Open Access

    UpToDate versus DynaMed: a cross-sectional study comparing the speed and accuracy of two point-of-care information tools

    by Glyneva Bradley-Ridout, Erica Nekolaichuk, Trevor Jamieson, Claire Jones, Natalie Morson, Rita Chuang, Elena Springall

    Objective: To compare the accuracy, time to answer, user confidence, and user satisfaction between UpToDate and DynaMed (formerly DynaMed Plus), which are two popular point-of-care information tools.Methods: A crossover study was conducted with medical residents in obstetrics and gynecology and family medicine at the University of Toronto in order to compare the speed and accuracy with which they retrieved answers to clinical questions using UpToDate and DynaMed. Experiments took place between February 2017 and December 2019. Following a short tutorial on how to use each tool and completion of a background survey, participants attempted to find answers to two clinical questions in each tool. Time to answer each question, the chosen answer, confidence score, and satisfaction score were recorded for each clinical question.Results: A total of 57 residents took part in the experiment, including 32 from family medicine and 25 from obstetrics and gynecology. Accuracy in clinical answers was equal between UpToDate (average 1.35 out of 2) and DynaMed (average 1.36 out of 2). However, time to answer was 2.5 minutes faster in UpToDate compared to DynaMed. Participants were also more confident and satisfied with their answers in UpToDate compared to DynaMed.Conclusions: Despite a preference for UpToDate and a higher confidence in responses, the accuracy of clinical answers in UpToDate was equal to those in DynaMed. Previous exposure to UpToDate likely played a major role in participants’ preferences. More research in this area is recommended.


  • Open Access

    Reducing day 3 baseline monitoring bloodwork and ultrasound for patients undergoing timed intercourse and intrauterine insemination treatment cycles

    by Victoria O’dRiscoll, Ilinca Georgescu, Irene Koo, Rebecca Arthur, Rita Chuang, Jillian Ann Dempsey, Giulia De Franco, Claire Ann Jones

    Background: In the current context of a global pandemic it is imperative for fertility clinics to consider the necessity of individual tests and eliminate those that have limited utility and may impose unnecessary risk of exposure. The purpose of this study was to implement and evaluate a multi-modal quality improvement (QI) strategy to promote resource stewardship by reducing routine day 3 (d3) bloodwork and transvaginal ultrasound (TVUS) for patients undergoing intrauterine insemination (IUI) and timed intercourse (IC) treatment cycles. Methods: After literature review, clinic stakeholders at an academic fertility centre met to discuss d3 testing utility and factors contributing to d3 bloodwork/TVUS in IC/IUI treatment cycles. Consensus was reached that it was unnecessary in patients taking oral/no medications. The primary intervention changed the default setting on the electronic order set to exclude d3 testing for IC/IUI cycles with oral/no medications. Exceptions required active test selection. Protocols were updated and education sessions were held. The main outcome measure was the proportion of cycles receiving d3 bloodwork/TVUS during the 8-week post-intervention period compared with the 8-week pre-intervention period. Balancing measures included provider satisfaction, pregnancy rates, and incidence of cycle cancellation. Results: A significant reduction in the proportion of cycles receiving d3 TVUS (57.2% vs 20.8%, p < 0.001) and ≥ 1 blood test (58.6% vs 22.8%, p < 0.001) was observed post-intervention. There was no significant difference in cycle cancellation or pregnancy rates pre- and post-intervention (p = 0.86). Treatment with medications, cyst history, prescribing physician, and treatment centre were associated with receiving d3 bloodwork/TVUS. 74% of providers were satisfied with the intervention. Conclusion: A significant reduction in IC/IUI treatment cycles that received d3 bloodwork/TVUS was achieved without measured negative treatment impacts. During a pandemic, eliminating routine d3 bloodwork/TVUS represents a safe way to reduce monitoring appointments and exposure.